Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $50.80 and last traded at $50.28, with a volume of 19,626 shares. The stock had previously closed at $49.43.
Analyst Ratings Changes
GRDN has been the subject of several analyst reports. KeyCorp initiated coverage on Guardian Pharmacy Services in a report on Tuesday, September 22nd. They set an "overweight" rating and a $52.00 price objective for the company. Wall Street Zen upgraded Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a research note on Saturday. Truist Financial upped their target price on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a "buy" rating in a research report on Monday, September 21st. Weiss Ratings upgraded Guardian Pharmacy Services from a "buy (b-)" rating to a "buy (b)" rating in a research note on Monday, November 9th. Finally, Oppenheimer raised their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. Nine investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $45.57.
Check Out Our Latest Research Report on Guardian Pharmacy Services
Guardian Pharmacy Services Stock Performance
The company has a market cap of $3.18 billion, a PE ratio of 42.91, a price-to-earnings-growth ratio of 2.58 and a beta of 0.06. The stock has a 50 day moving average of $42.65 and a 200-day moving average of $38.87.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.02. The business had revenue of $371.07 million for the quarter, compared to the consensus estimate of $365.76 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 5.13%. Equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.
Hedge Funds Weigh In On Guardian Pharmacy Services
Hedge funds and other institutional investors have recently bought and sold shares of the business. Aquatic Capital Management LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter worth $235,000. Lighthouse Investment Partners LLC raised its stake in shares of Guardian Pharmacy Services by 28.9% during the 3rd quarter. Lighthouse Investment Partners LLC now owns 8,572 shares of the company's stock valued at $350,000 after buying an additional 1,920 shares during the last quarter. First Trust Advisors LP raised its stake in shares of Guardian Pharmacy Services by 30.3% during the 3rd quarter. First Trust Advisors LP now owns 601,238 shares of the company's stock valued at $24,518,000 after buying an additional 139,931 shares during the last quarter. Voya Investment Management LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $238,000. Finally, Teachers Retirement System of The State of Kentucky lifted its holdings in shares of Guardian Pharmacy Services by 54.7% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 38,372 shares of the company's stock valued at $1,565,000 after buying an additional 13,572 shares during the period.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents' medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.